scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198309293091317 |
P698 | PubMed publication ID | 6684209 |
P2093 | author name string | Bell R | |
Sullivan JR | |||
Leyden MJ | |||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 796 | |
P577 | publication date | 1983-09-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Decreased cisplatin-induced nausea and vomiting with chronic alcohol ingestion | |
P478 | volume | 309 |
Q41722660 | 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy |
Q42528919 | A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy |
Q48035092 | Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea |
Q34582576 | Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline-based regimens |
Q38894275 | Controlling chemotherapy-induced nausea requires further improvement: symptom experience and risk factors among Korean patients. |
Q70785527 | Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy |
Q91944817 | Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian Perspective |
Q47572599 | Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy |
Q48218900 | Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study |
Q36564254 | Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary |
Q40815803 | Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria). |
Q40740167 | Methodological issues in antiemetic studies |
Search more.